| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/23/2013 | CN102886058A Vehicle refreshing perfume for drivers |
| 01/23/2013 | CN102886041A Combination for improving memory and preparation method thereof |
| 01/23/2013 | CN102886040A Combination for enhancing memory and preparation method thereof |
| 01/23/2013 | CN102886034A Group of notopterygium root rheumatism pain tablets |
| 01/23/2013 | CN102886030A Traditional Chinese medicine refreshment intravenous injection nasal delivery preparation used for resuscitation and refreshment and preparation method of nasal delivery preparation |
| 01/23/2013 | CN102886022A Chinese medicinal preparation for treating insomnia and dreaminess |
| 01/23/2013 | CN102886020A Chinese medicinal composition for treating epilepsy |
| 01/23/2013 | CN102885997A Traditional Chinese medicine for treating neurodermatitis |
| 01/23/2013 | CN102885993A Application of Tibetan medicament composition in preparation of medicament for treating convulsion |
| 01/23/2013 | CN102885985A Preparation method and application of rhizoma gastrodiae and rhizoma chuanxiong compound extract |
| 01/23/2013 | CN102885977A Composition with memory improving function |
| 01/23/2013 | CN102885956A Traditional Chinese medicine composition for aiding sleep and preparation method of composition |
| 01/23/2013 | CN102885947A Method for processing prepared pinellia tuber, product of prepared pinellia tuber and application of product |
| 01/23/2013 | CN102885913A Fresh essential balm |
| 01/23/2013 | CN102885868A Novel application of Pien Tze Huang and preparation of Pien Tze Huang to protection of memory function and resistance of cerebral ischemia |
| 01/23/2013 | CN102885838A Novel use of catalpol in preparation of drug for treating cerebral arterial thrombosis reperfusion injuries |
| 01/23/2013 | CN102885816A Application of compound 6-(4-chlorophenoxy)-tetrazolo [5,1-a] phthalazine to preparation of medicine for treating depression |
| 01/23/2013 | CN102885815A Application of stizolobium cochinchinensis seed extract to preparation of medicament for treating Parkinson's disease accompanied by sleep disorder |
| 01/23/2013 | CN102885812A Lappaconite hydrobromide sustained-release tablets and preparation method thereof |
| 01/23/2013 | CN102885804A Dopamine prodrug composition and preparation method thereof |
| 01/23/2013 | CN102885796A Lacosamide tablet for treating epilepsy and preparation method for lacosamide tablet |
| 01/23/2013 | CN102885760A Hydrobromic acid galanthamine controlled-release dry suspension and preparation method thereof |
| 01/23/2013 | CN102885539A Drug pillow capable of relieving night terrors of children |
| 01/23/2013 | CN102885346A Wheat, jujube and rose beverage for nourishing heart and soothing nerves and preparation method thereof |
| 01/23/2013 | CN102885221A Functional feed for preventing hepatonecrosis and hepatic encephalopathy of Alosa sapidissima |
| 01/23/2013 | CN102406606B Solid quetiapine fumarate liposome preparation |
| 01/23/2013 | CN102293892B Chinese medicinal preparation for treating nervous headache |
| 01/23/2013 | CN102232980B Preparation method for eleutheroside |
| 01/23/2013 | CN102078310B Generally linear effervescent oral fentanyl dosage form and methods of administering |
| 01/23/2013 | CN102076340B Transdermal patch containing fentanyl or salt thereof |
| 01/23/2013 | CN102020607B 6-aminoniacinamide derivatives with histone deacetylase inhibiting activity, preparation method and application thereof |
| 01/23/2013 | CN101888830B 透皮递送系统 Transdermal delivery systems |
| 01/23/2013 | CN101855227B Heterocyclic derivatives |
| 01/23/2013 | CN101742992B The application of 5-methyl-1,3-benzenediol or derivatives thereof in the preparation of medicines and functional foods for treatment or prevention of depression |
| 01/23/2013 | CN101721431B Compound nano pearl starch ball and production process thereof |
| 01/23/2013 | CN101657192B Medicinal composition, food or drink having effect of enhancing parasympathetic nervous actions |
| 01/23/2013 | CN101490017B Therapeutic piperazines as pde4 inhibitors |
| 01/23/2013 | CN101314000B Gastrodia tuber eucommia health care capsule and preparation method thereof |
| 01/23/2013 | CN101193914B Antibodies directed against amyloid-beta peptide and methods using same |
| 01/22/2013 | US8357670 Oligomeric compounds for the modulation of HIF-1A expression |
| 01/22/2013 | US8357658 Medicament for treating Parkinson'S disease |
| 01/22/2013 | US8357399 Tamper-resistant oral opioid agonist formulations |
| 01/22/2013 | CA2695372C Methods for treating dependence |
| 01/22/2013 | CA2685214C Improved controlled release oral dosage form |
| 01/22/2013 | CA2667397C Oleanane triterpene saponin compounds which are effective on treatment of dementia and mild cognitive impairment (mci), and improvement of cognitive function |
| 01/22/2013 | CA2565051C Novel use of peptide compounds for treating dyskinesia |
| 01/22/2013 | CA2560241C Carbohydrate-derivatized liposomes for targeting cellular carbohydrate recognition domains of ctl/ctld lectins, and intracellular delivery of therapeutically active compounds |
| 01/22/2013 | CA2558783C Oral morphine multiparticulate formulation |
| 01/22/2013 | CA2554461C Method for obtaining precursor z and use thereof for the production of a means for therapy of human molybdenum cofactor deficiency |
| 01/22/2013 | CA2550053C Tetrahydrobenzazepines and their use in the modulation of the dopamine d3 receptor |
| 01/22/2013 | CA2546672C Use of c-(2-phenyl-cyclohexyl)-methylamine compounds for the treatment of anxiety disorders |
| 01/22/2013 | CA2483525C Method of measuring neprilysin activity |
| 01/22/2013 | CA2402402C Use of (r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane for treating adverse effects of anti-parkinsonian drugs |
| 01/22/2013 | CA2325629C Crystalline forms of 1s-[1alpha (2s*,3r*), 9alpha]-6, 10-dioxo-n- (2-ethoxy-5 -oxo-tetrahydro-3 -furanyl) -9-[[(1-isoquinolyl) carbonyl]-amino] octahydro-6h -piridazino[1, 2-a][1,2] diazepin- 1-carboxamide |
| 01/17/2013 | WO2013010176A2 Pharmacophores for amyloid fibers involved in alzheimer's disease |
| 01/17/2013 | WO2013010132A1 Prevention and treatment of pain using antibodies to lysophosphatidic acid |
| 01/17/2013 | WO2013010028A2 COMPOSITIONS AND METHODS FOR IMPROVED CaMKII INHIBITORS AND USES THEREOF |
| 01/17/2013 | WO2013009981A2 Treating neurological disease or injury with a dynamin-related protein 1 (drp1) encoding nucleic acid |
| 01/17/2013 | WO2013009830A1 Methods of treatment |
| 01/17/2013 | WO2013009827A1 Methods of treatment |
| 01/17/2013 | WO2013009812A1 Methods of treatment |
| 01/17/2013 | WO2013009810A1 Methods of treatment |
| 01/17/2013 | WO2013009647A1 Glutathione analogs and uses thereof |
| 01/17/2013 | WO2013009543A1 Polycyclic pyrrolidine-2,5-dione derivatives as -formyl peptide receptor like-1 (fprl-1) receptor modulators |
| 01/17/2013 | WO2013009517A1 (THIENO[2,3-b][1,5]BENZOXAZEPIN-4-YL)PIPERAZIN-1-YL COMPOUNDS AS DUAL ACTIVITY H1 INVERSE AGONISTS/5-HT2A ANTAGONISTS |
| 01/17/2013 | WO2013009259A1 Novel compounds and their use in therapy |
| 01/17/2013 | WO2013009186A1 Nicotinamide compositions and the therapeutic use thereof |
| 01/17/2013 | WO2013008162A1 Novel trifluoromethyl-oxadiazole derivatives and their use in the treatment of disease |
| 01/17/2013 | WO2013008093A1 Terpene analogues and uses thereof for treating neurological conditions |
| 01/17/2013 | WO2013008044A1 Synthesis of (+) and (-) 1 -(5,5-diphenyltetrahydrofuran-3- yl)-n,n-dimethylmethanamine, (+) and (-) 1-(2,2-diphenyltetrahydrofuran-3-yl)-n,n- dimethylmethanamine and (+) and (-) 1-(2,2- dffhenyltetrahydrofuran-3-yl)-n-metihylmethanamine |
| 01/17/2013 | WO2013007986A1 Orvinol and thevinol derivatives useful in the treatment of drug and alcohol abuse |
| 01/17/2013 | WO2013007874A1 A transgenic animal comprising a deletion or functional deletion of the 3'utr of an endogenous gene. |
| 01/17/2013 | WO2013007698A1 Pharmaceutical composition for neurological disorders |
| 01/17/2013 | WO2013007676A1 Aminomethyl quinolone compounds |
| 01/17/2013 | WO2013007663A1 2-benzylsulfanyl[1,3,4]-oxadiazole derivatives, and medical use thereof |
| 01/17/2013 | WO2013007621A1 Positive allosteric modulators of nicotinic acetylcholine receptor |
| 01/17/2013 | WO2013007381A1 A new therapeutical composition containing apomorphine as active ingredient |
| 01/17/2013 | WO2013006978A1 Neuroprotective pepties that inhbit interaction between palmitoyl acyl transferase zinc- finger dhhc type containing 17 (zd17) and c-jun n-terminal kinase (jnk) |
| 01/17/2013 | WO2012149478A3 Agents useful for treating friedreich's ataxia and other neurodegenerative diseases |
| 01/17/2013 | WO2012149406A3 Assessing and treating humans with long qt syndrome |
| 01/17/2013 | WO2012148926A3 Neurodegenerative disorders and muscle diseases implicating pufas |
| 01/17/2013 | WO2012148225A3 Sustained-release pharmaceutical composition comprising donepezil or pharmaceutically acceptable salt thereof having improved dissolution stability and method for manufacturing the same |
| 01/17/2013 | WO2012147051A3 Food, particularly a beverage for human consumption |
| 01/17/2013 | WO2012146724A3 Novel rock inhibitors |
| 01/17/2013 | WO2012145651A3 Compounds for the treatment of neuropsychiatric disorders |
| 01/17/2013 | WO2012145428A3 Altering protein concentrations in cerebrospinal fluid and/or brain interstitial fluid |
| 01/17/2013 | WO2012142388A3 Methods, compounds and pharmaceutical compositions for treating anxiety and mood disorders |
| 01/17/2013 | WO2012142256A3 Modulators of mitochondrial protein import |
| 01/17/2013 | WO2012138599A3 Hepatocyte growth factor mimics as therapeutic agents |
| 01/17/2013 | US20130018109 Skin and hair treatments |
| 01/17/2013 | US20130018091 Treatment of allodynia and hyperalgesia |
| 01/17/2013 | US20130018090 Low-dose doxepin for treatment of sleep disorders in elderly patients |
| 01/17/2013 | US20130018081 AChE ANTISENSE OLIGONUCLEOTIDE AS AN ANTI-INFLAMMATORY AGENT |
| 01/17/2013 | US20130018071 Solid Forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
| 01/17/2013 | US20130018070 Modulators of cystic fibrosis transmembrane conductance regulator |
| 01/17/2013 | US20130018068 Spirocycles as inhibitors of 11-beta hydroxyl steroid dehydrogenase type 1 |
| 01/17/2013 | US20130018067 Polycyclic pyrrolidine-2,5-dione derivatives as -formyl peptide receptor like-1 (fprl-1) receptor modulators |
| 01/17/2013 | US20130018066 Heterocyclic aspartyl protease inhibitors |
| 01/17/2013 | US20130018064 Amino Heteroaryl Compounds as Beta-Secretase Modulators and Methods of Use |
| 01/17/2013 | US20130018063 Organic compounds |